Share This

Related Topics News - Drugs

     
 < Previous page   Title only   |   Print    Next page > 
     
《大行》高盛對中國醫療健康股投資評級及目標價(表)

2025-03-13T  
《大行》高盛降金斯瑞目標價至27.34元 去年銷售額達指引下限

2025-03-13T  
《大行》大和:金斯瑞生物科技今年有望轉盈 降目標價至25元

2025-03-13T  
《大行》中銀國際降金斯瑞目標價至21元 維持「買入」評級

2025-03-13T  
《業績》金斯瑞生物科技去年虧轉盈賺29.62億美元 不派息

2025-03-12T  
新華製藥麻醉輔助用藥獲國家藥監局批准註冊

2025-03-11T  
石四藥集團安瓿包裝碳酸氫鈉注射液取得藥品生產註冊批件

2025-03-10T  
石四藥治療高血壓藥獲藥監局批准登記為原料藥

2025-03-05T  
據報上海醫藥等成立科技公司拓生物基材料製造業務

2025-03-05T  
山東新華製藥處方藥獲批藥品補充申請

2025-03-03T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.